Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China · Delayed Price · Currency is CNY 9.33
-0.42 (-4.31%)
At close: May 21, 2026
SHA:688189 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -154.97 | -149.75 | -356.9 | -10.87 | -78.83 | -161.88 |
Depreciation & Amortization | 35.94 | 35.94 | 37.08 | 37.22 | 47.89 | 37.61 |
Other Amortization | 0.05 | 0.05 | 1.79 | 0.36 | 0.55 | 0.4 |
Loss (Gain) From Sale of Assets | -2.53 | -2.53 | -0.59 | -0.17 | - | - |
Asset Writedown & Restructuring Costs | 41.55 | 41.55 | 31.98 | - | 2.74 | 16.72 |
Loss (Gain) From Sale of Investments | - | - | - | 14.91 | 5.63 | -3.33 |
Provision & Write-off of Bad Debts | - | - | 283.7 | 87.11 | 106.17 | 108.62 |
Other Operating Activities | -87.19 | 18.81 | -25.66 | 24.13 | 21.29 | 4.21 |
Change in Accounts Receivable | 178.32 | 178.32 | 65.9 | 89.27 | -240.57 | -222.41 |
Change in Inventory | 28.16 | 28.16 | -29.63 | 3.09 | 24.57 | -12.45 |
Change in Accounts Payable | -76.05 | -76.05 | -11.9 | -26.61 | -67.52 | 207.57 |
Change in Other Net Operating Assets | 22.87 | 22.87 | - | - | - | - |
Operating Cash Flow | 3.36 | 114.57 | 1.39 | 215.23 | -160.09 | -63.11 |
Operating Cash Flow Growth | -94.75% | 8121.98% | -99.35% | - | - | - |
Capital Expenditures | -49.22 | -79.8 | -58.43 | -31.49 | -41.01 | -113.59 |
Sale of Property, Plant & Equipment | 4.56 | 4.56 | 1.88 | 0.06 | - | - |
Investment in Securities | - | - | 100 | -100.46 | - | 660 |
Other Investing Activities | 120 | - | 0.85 | - | 212.37 | -194.11 |
Investing Cash Flow | 75.34 | -75.24 | 44.31 | -131.89 | 171.37 | 352.3 |
Short-Term Debt Issued | - | - | 119 | 300 | - | - |
Long-Term Debt Issued | - | 10 | 100 | 138.8 | 490 | 465 |
Total Debt Issued | 10 | 10 | 219 | 438.8 | 490 | 465 |
Short-Term Debt Repaid | - | - | -323.8 | -653.78 | - | - |
Long-Term Debt Repaid | - | -219 | - | - | -502.11 | -261.46 |
Total Debt Repaid | -219 | -219 | -323.8 | -653.78 | -502.11 | -261.46 |
Net Debt Issued (Repaid) | -209 | -209 | -104.8 | -214.98 | -12.11 | 203.54 |
Repurchase of Common Stock | - | - | -10 | - | - | - |
Common Dividends Paid | -2.75 | -2.71 | -5.23 | -15.82 | -16.36 | -56.31 |
Other Financing Activities | -24.37 | -21.52 | 2.86 | -4.28 | - | -5.1 |
Financing Cash Flow | -236.12 | -233.23 | -117.16 | -235.08 | -28.47 | 142.13 |
Net Cash Flow | -157.43 | -193.9 | -71.46 | -151.74 | -17.2 | 431.32 |
Free Cash Flow | -45.86 | 34.77 | -57.03 | 183.74 | -201.1 | -176.7 |
Free Cash Flow Margin | -36.01% | 24.50% | -21.66% | 25.52% | -28.78% | -23.76% |
Free Cash Flow Per Share | -0.17 | 0.13 | -0.21 | 0.67 | -0.73 | -0.64 |
Cash Income Tax Paid | 8.95 | 8.64 | 40.69 | 89.02 | 76.84 | 94.19 |
Levered Free Cash Flow | 6.14 | 59.58 | 86.72 | 172.15 | -102.39 | -204.91 |
Unlevered Free Cash Flow | 6.14 | 59.58 | 90.1 | 181.68 | -88.61 | -194.95 |
Change in Working Capital | 170.51 | 170.51 | 30 | 62.55 | -265.52 | -65.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.